Reinventing a 90-Year-Old TB Test: Can Needle-Free Tech Fix a Global Bottleneck?

Reinventing a 90-Year-Old TB Test: Can Needle-Free Tech Fix a Global Bottleneck?

By, Admin 27 March 2026

Tuberculosis testing hasn’t changed much in nearly a century.That might finally be about to  shift.

PharmaJet is teaming up with Brazilian Tuberculosis Research Network to test a needle-free version of the traditional TB skin test. The goal is simple: make testing faster, less painful, and more likely to be completed.

The Problem: Testing Is Where TB Control Breaks Down

Tuberculosis isn’t rare. It’s everywhere.

Key numbers:

  • ~25% of the global population carries TB infection
  • 5–10% will develop active disease
  • 1.23 million deaths in 2024 alone

The bigger issue? Detection. The Tuberculin Skin Test (TST) helps identify infected individuals before symptoms appear. That’s critical for prevention.

But in practice, TB programs struggle. A The Lancet publication highlighted a major weakness:

  • Patients often drop out during or after testing
  • Pain, fear, and inconvenience reduce completion rates

Translation: even when testing exists, people don’t follow through.

The Experiment: Replacing Needles With Pressure

The upcoming clinical study will evaluate PharmaJet’s Tropis ID Needle-Free Injection System. Instead of a needle, it uses a high-pressure stream to deliver the test intradermally.

What the study will measure:

  • Accuracy vs traditional TST
  • Workflow efficiency for healthcare workers
  • Safety outcomes
  • Patient and caregiver acceptability

This isn’t just about clinical performance. It’s about real-world usability.

Why Needle-Free Might Win?

Needle-free systems solve problems that rarely show up in clinical endpoints—but kill programs in reality.

What previous studies show:

  • Administration time
  • Acceptance among caregivers and healthcare workers
  • Adverse events by 54% (polio vaccine study)
  • Pain and soreness by >68%

That last point matters more than it looks. Less pain → higher compliance → better public health outcomes.

What PharmaJet Is Betting On?

According to CEO Wouter Latour:

  • Over 20 million Tropis injections have already been deployed globally
  • The system improves immunization coverage and cost-effectiveness
  • Interest is expanding beyond vaccines into:
    • Oncology
    • Skin testing (like TB)

This TB study is a strategic expansion, not a one-off experiment.

Why This Matters More Than It Looks?

Dr. Anete Trajman puts it bluntly:

  • TB prevention is the key to elimination.
  • And prevention starts with detection.

If a needle-free TST can:

  • Reduce fear
  • Increase completion rates
  • Improve workflow in crowded clinics

…it could fix one of the weakest links in TB control.

The Bigger Picture

TB remains:

  • The leading cause of death from a single infectious agent
  • Among the top 10 causes of death globally

And yet, the primary screening tool is nearly 90 years old. That’s the gap PharmaJet is targeting.

Final Take

This isn’t a breakthrough drug story. It’s more subtle—and arguably more important.

  • No new molecule
  • No new biology
  • Just a better way to deliver an old test

If this works, the impact won’t come from innovation alone. It will come from more people actually completing the test. And in TB control, that’s everything.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!